Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA: Cancer J Clin 60(5):277–300. https://doi.org/10.3322/caac.20073

Ban KA, Godellas CV (2014) Epidemiology of breast cancer. Surg Oncol Clin 23(3):409–422

Google Scholar 

Zeeneldin AA, Ramadan M, Gaber AA, Taha FM (2013) Clinico-pathological features of breast carcinoma in elderly Egyptian patients: a comparison with the non-elderly using population-based data. J Egypt Natl Canc Inst 25(1):5–11

PubMed  Google Scholar 

Van der Ploeg I, Hobbelink M, Van Den Bosch M, Mali WTM, Rinkes IB, Van Hillegersberg R (2008) ‘Radioguided occult lesion localisation’(ROLL) for non-palpable breast lesions: a review of the relevant literature. Eur J Surg Oncol (EJSO) 34(1):1–5

PubMed  Google Scholar 

Hennessy BT, Hortobagyi GN, Rouzier R, Kuerer H, Sneige N, Buzdar AU et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23(36):9304–9311

PubMed  Google Scholar 

Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ et al (2016) Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 34(10):1072

CAS  PubMed  PubMed Central  Google Scholar 

Kim WH, Kim HJ, Kim SH et al. (2019) Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study. BMC Cancer 19(1):859. https://doi.org/10.1186/s12885-019-6095-1. Published 2019 Aug 30

Motomura K (2015) Sentinel node biopsy for breast cancer: past, present, and future. Breast Cancer 22(3):212–220

PubMed  Google Scholar 

Cao S, Liu X, Cui J, Liu X, Zhong J, Yang Z et al (2021) Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: an up-to-date meta-analysis of 3,578 patients. Breast 59:256–269

PubMed  PubMed Central  Google Scholar 

Tee SR, Devane LA, Evoy D, Rothwell J, Geraghty J, Prichard RS et al (2018) Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer. Br J Surg 105(12):1541–1552

CAS  PubMed  Google Scholar 

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455–1461

CAS  PubMed  PubMed Central  Google Scholar 

Caudle AS, Cupp JA, Kuerer HM (2014) Management of axillary disease. Surg Oncol Clin 23(3):473–486

Google Scholar 

Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B et al (2015) Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg 150(2):137–143

PubMed  PubMed Central  Google Scholar 

Morrow M, Dang CT (2013) Sentinel node biopsy after neoadjuvant chemotherapy: a new standard for patients with axillary metastases? JAMA 310(14):1449–1450

CAS  PubMed  Google Scholar 

Goyal A, Puri S, Marshall A, Valassiadou K, Hoosein MM, Carmichael AR et al (2021) A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients. Breast Cancer Res Treat 185(2):433–440

CAS  PubMed  Google Scholar 

Choy N, Lipson J, Porter C, Ozawa M, Kieryn A, Pal S et al (2015) Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Ann Surg Oncol 22(2):377–382

PubMed  Google Scholar 

Park S, Koo JS, Kim GM, Sohn J, Kim SI, Cho YU et al (2018) Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. Cancer Res Treat: Off J Korean Cancer Assoc 50(3):801

CAS  Google Scholar 

Kim WH, Kim HJ, Jung JH, Park HY, Lee J, Kim WW et al (2018) Ultrasound-guided restaging and localization of axillary lymph nodes after neoadjuvant chemotherapy for guidance of axillary surgery in breast cancer patients: experience with activated charcoal. Ann Surg Oncol 25(2):494–500

PubMed  Google Scholar 

Natsiopoulos I, Intzes S, Liappis T, Zarampoukas K, Zarampoukas T, Zacharopoulou V et al (2019) Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0 after treatment. Clin Breast Cancer 19(3):208–215

PubMed  Google Scholar 

Straver M, Loo C, Alderliesten T, Rutgers E, Vrancken PM (2010) Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. J Br Surg 97(8):1226–1231

CAS  Google Scholar 

Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA et al (2015) Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg 261(2):378–382

PubMed  Google Scholar 

Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD et al. (2014) Breast cancer version 3.2014. J Natl Compr Cancer Netw 12(4):542–90